Showing codes J7308 (Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)) — J7352 (Afamelanotide implant, 1 mg)

J7308 - Aminolevulinic acid hcl top
Long description: Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
Code added date: 20020101.
Code effective date: 20040101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7309 - Methyl aminolevulinate, top
Long description: Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram
Code added date: 20110101.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7310 - Ganciclovir long act implant
Long description: Ganciclovir, 4.5 mg, long-acting implant
Code added date: 19970101.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7311 - Inj., retisert, 0.01 mg
Long description: Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg
Code added date: 20070101.
Code effective date: 20191001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7312 - Dexamethasone intra implant
Long description: Injection, dexamethasone, intravitreal implant, 0.1 mg
Code added date: 20110101.
Code effective date: 20110101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7313 - Inj., iluvien, 0.01 mg
Long description: Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg
Code added date: 20160101.
Code effective date: 20191001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7314 - Inj., yutiq, 0.01 mg
Long description: Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg
Code added date: 20191001.
Code effective date: 20191001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7315 - Ophthalmic mitomycin
Long description: Mitomycin, ophthalmic, 0.2 mg
Code added date: 20130101.
Code effective date: 20160101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7316 - Inj, ocriplasmin, 0.125 mg
Long description: Injection, ocriplasmin, 0.125 mg
Code added date: 20140101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7318 - Inj, durolane 1 mg
Long description: Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg
Code added date: 20190101.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7320 - Genvisc 850, inj, 1mg
Long description: Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg
Code added date: 20170101.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7321 - Hyalgan supartz visco-3 dose
Long description: Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose
Code added date: 20080101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7322 - Hymovis injection 1 mg
Long description: Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg
Code added date: 20170101.
Code effective date: 20170101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7323 - Euflexxa inj per dose
Long description: Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose
Code added date: 20080101.
Code effective date: 20080101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7324 - Orthovisc inj per dose
Long description: Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose
Code added date: 20080101.
Code effective date: 20080101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7325 - Synvisc or synvisc-one
Long description: Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg
Code added date: 20100101.
Code effective date: 20170101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7326 - Gel-one
Long description: Hyaluronan or derivative, gel-one, for intra-articular injection, per dose
Code added date: 20120101.
Code effective date: 20170101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7327 - Monovisc inj per dose
Long description: Hyaluronan or derivative, monovisc, for intra-articular injection, per dose
Code added date: 20150101.
Code effective date: 20150101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7328 - Gelsyn-3 injection 0.1 mg
Long description: Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg
Code added date: 20160101.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7329 - Inj, trivisc 1 mg
Long description: Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg
Code added date: 20190101.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7330 - Cultured chondrocytes implnt
Long description: Autologous cultured chondrocytes, implant
Code added date: 20010101.
Code effective date: 20020701.
Pricing Indicator Code(s): 57 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7331 - Synojoynt, inj., 1 mg
Long description: Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg
Code added date: 20191001.
Code effective date: 20191001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7332 - Inj., triluron, 1 mg
Long description: Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg
Code added date: 20191001.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7333 - Visco-3 inj dose
Long description: Hyaluronan or derivative, visco-3, for intra-articular injection, per dose
Code added date: 20200701.
Code effective date: 20210401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7335 - Capsaicin 8% patch
Long description: Capsaicin 8% patch, per 10 square centimeters
Code added date: 20110101.
Code effective date: 20150101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7336 - Capsaicin 8% patch
Long description: Capsaicin 8% patch, per square centimeter
Code added date: 20150101.
Code effective date: 20150101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7340 - Carbidopa levodopa ent 100ml
Long description: Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml
Code added date: 20160101.
Code effective date: 20200101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7342 - Ciprofloxacin otic susp 6 mg
Long description: Instillation, ciprofloxacin otic suspension, 6 mg
Code added date: 20170101.
Code effective date: 20170101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7345 - Aminolevulinic acid, 10% gel
Long description: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg
Code added date: 20180101.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J7351 - Inj bimatoprost itc imp1mcg
Long description: Injection, bimatoprost, intracameral implant, 1 microgram
Code added date: 20201001.
Code effective date: 20201001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J7352 - Afamelanotide implant, 1 mg
Long description: Afamelanotide implant, 1 mg
Code added date: 20210101.
Code effective date: 20210101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF